Abstract: The present invention provides an isolated or recombinant protein consisting of the amino acid sequence according to SEQ ID NO: 3 or SEQ ID: NO: 4 and its use in the prevention or treatment of an inflammatory condition.
Type:
Application
Filed:
October 31, 2020
Publication date:
August 5, 2021
Applicant:
IMMUNE REGULATION LIMITED
Inventors:
Valerie Mary Corrigall, Gabriel Stavros Panayi
Abstract: The present invention provides an isolated or recombinant protein consisting of the amino acid sequence according to SEQ ID NO: 3 or SEQ ID: NO: 4 and its use in the prevention or treatment of an inflammatory condition.
Type:
Grant
Filed:
June 13, 2018
Date of Patent:
December 8, 2020
Assignee:
IMMUNE REGULATION LIMITED
Inventors:
Valerie Mary Corrigall, Gabriel Stavros Panayi